by Mednow | Jun 29, 2022 | Press Release
Mednow’s Liver Care Canada Partners with HepCURE with the Goal of Eliminating Hepatitis C in Canada by 2030 Mednow entered into a partnership agreement with HepCURE, one of Canada’s leading hepatitis C screening and treatment providers, to achieve the goal of...
by Mednow | Jun 15, 2022 | Press Release
Mednow Beats Guidance & Achieves Record Q3 2022 Financial Results with 225% Q/Q Revenue Growth & 4800% Y/Y Revenue Growth and Appoints Ali Reyhany CEO Q3/22 revenue increased over 225% quarter-over-quarter, and more than 4,800% year-over-year;Mednow patient...
by Mednow | Jun 8, 2022 | Press Release
Mednow to Host Quarterly Conference Call on Wednesday June 15, 2022, at 8:30am EST on its Third-Quarter 2022 Financial Results TORONTO–(BUSINESS WIRE)–Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy, is...
by Mednow | May 9, 2022 | Press Release
Mednow Announces the Graduation to OTCQX Trading, to expand Access to U.S. Investors Toronto, ON. (May 9th, 2022) – Mednow Inc. (“Mednow’’ or the “Company”) (TSXV: MNOW) (OTCQX:MDNWF), Canada’s on-demand virtual pharmacy, is pleased to announce that its common...
by Mednow | Apr 26, 2022 | Press Release
Mednow Provides Revenue Guidance on Fiscal Q3 2022, a Projected Record C$5 – C$5.5 Million in Quarterly Revenue, Q/Q Growth of Approx. 175% In fiscal Q3 2022, for the 3 months ended April 30, 2022, Mednow is forecasted to have quarterly revenue of C$5 –...
by Mednow | Apr 18, 2022 | Press Release
Mednow.ca Launches a Licenced Pharmacy in Manitoba; Designed to Improve Health Outcomes Through Unlimited Pharmacist Consults, and More April 18, 2022 (Toronto, ON) – Mednow Inc. (“Mednow” or the “Company”) (TSXV:MNOW), Canada’s on-demand virtual pharmacy,...
Recent Comments